About ChemoMetec
ChemoMetec is a publicly listed company based in Allerød (Denmark) founded in 1997. Automated cell counters and analyzers are developed for biological applications. The company has 174 employees. Its website chemometec.com draws about 32 thousand monthly visits. ChemoMetec offers products and services including NucleoCounter® NC-3000™, XcytoMatic® 40, NucleoCounter® NC-250™, and XcytoMatic® 30. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Cell Biology. Its legal entity is ChemoMetec A/S.
Company details
ChemoMetec develops automated cell counters and analyzers, as well as associated consumables. Its flagship product range NucleoCounter has four different cytometers that use automated image analysis and fluorescent markers for cell counting, a sperm counter, a yeast cell counter, and two different somatic cell counters. Assays that can be performed on the cytometers include cell death and apoptosis assays, cell cycle assays, DNA fragmentation assays, transfection efficiency assays, mitochondrial potential assays, cell viability assays, vitality assays, mammalian and aggregated cell assays, whole blood assays, and the companys proprietary FlexiCyte assay for mammalian cell analysis.
- Annual Revenue$77.91 M (USD)3.12as on Jun 30, 2026
- Net Profit$30.77 M (USD)15.53as on Jun 30, 2026
- EBITDA$40.53 M (USD)7.35as on Jun 30, 2026
- Latest Funding Round$395.61K (USD), Grant
Oct 2020
- Investors
- Employee Count174
Products & Services of ChemoMetec
ChemoMetec offers a comprehensive portfolio of products and services, including NucleoCounter® NC-3000™, XcytoMatic® 40, NucleoCounter® NC-250™, and XcytoMatic® 30.
Automated instrument for precise cell counting in bioprocessing
Device for cell density analysis in life sciences research
Compact tool for automated cell analysis in various applications
Instrument for reliable cell density measurements in biotech
Apps and channels of ChemoMetec
its YouTube channel ChemoMetec has 248 subscribers and 30 videos.
Videos from ChemoMetec
The most watched videos on ChemoMetec's YouTube channel, ChemoMetec (248 subscribers). Click a video to play it here.
More on ChemoMetec.
Funding Insights of ChemoMetec
- Total Rounds 1
- Last Round Grant — $395,612
- First Round $395,612
(Oct 2020)
- Investors Count 1
All 1 funding rounds of ChemoMetec with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2020 | $395,612 | Grant | – | – |
1 investors in total: 1 institutional.
Investors in ChemoMetec
ChemoMetec has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for ChemoMetec
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of ChemoMetec
9 people are tracked at ChemoMetec (5 in leadership, 4 in board & advisors); the tracked headcount is 174.
| Name | Role | Group |
|---|---|---|
Martin Glensbjerg | COO | Leadership |
Steen Søndergaard | CEO | Leadership |
Martin Helbo Behrens | Chief Financial Officer | Leadership |
Michael Packert | Head of Production | Leadership |
Niels Høy Nielsen | CFO | Leadership |
Peter Reich | Board Member | Board & advisors |
Kristine Færch | Board Member | Board & advisors |
Betina Hagerup | Board Member | Board & advisors |
Niels Thestrup | Chairman | Board & advisors |
Complete people profiles for ChemoMetec
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of ChemoMetec
ChemoMetec is a publicly listed company on the OMXCOP with ticker symbol CHEMM in Denmark, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date22 Dec 2006
- Listed onNASDAQ: CHEMM
- Listed entityChemoMetec A/S
- Exchange sectorHealth technology
- ISINDK0060055861
- Share price578.50 DKK (+1.67% on the day) · 2026-10-14
- Market capitalisation9,902,011,734.00 DKK
- Price to earnings49.9
- EPS (diluted, trailing year)11.60 DKK
- Dividend yield1.23%
- Volume (last session)9,311
Financials of ChemoMetec
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2026 | 511.1M DKK | 201.8M DKK | 265.9M DKK |
| 2025 | 495.6M DKK | 174.7M DKK | 247.7M DKK |
| 2024 | 407.4M DKK | 136.3M DKK | 178.3M DKK |
| 2023 | 442.3M DKK | 178.7M DKK | 242.4M DKK |
| 2022 | 427.2M DKK | 159.5M DKK | 215.3M DKK |
Detailed financial statements for ChemoMetec
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of ChemoMetec
3 dated milestones of ChemoMetec across 23 years, from founding to its latest funding, stage changes and deals.
- Founded ChemoMetec is founded.
- IPO Lists on the stock exchange (IPO).
- Funding First funding round of $396K.
Web traffic of ChemoMetec
The website of ChemoMetec (chemometec.com) receives about 31.8K visits a month.
- Monthly visits31.8K
▼ 2.7% vs previous month
Websites whose visitors overlap most with ChemoMetec. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
denovix.com | denovix.com | 100% | #921,351 | – | |
hemocytometer.org | hemocytometer.org | 95% | #1,582,396 | – | |
| incelligence.de | 88% | #6,180,619 | View details | ||
biorad-ads.com | biorad-ads.com | 84% | #8,876,068 | – | |
| nexcelom.com | 81% | View details | |||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 27 similar websites and full traffic analytics for ChemoMetec
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 27 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Chemometec
Complete news archive for ChemoMetec
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ChemoMetec
ChemoMetec was founded in 1997 and raised its 1st funding round 23 years after it was founded.
ChemoMetec is headquartered in Allerød, Denmark.
ChemoMetec has 174 employees.
Annual revenue of ChemoMetec is $77.91M as on Jun 30, 2026.
ChemoMetec develops automated cell counters and analyzers, as well as associated consumables. Its flagship product range NucleoCounter has four different cytometers that use automated image analysis and fluorescent markers for cell counting, a sperm counter, a yeast cell counter, and two different somatic cell counters. Assays that can be performed on the cytometers include cell death and apoptosis assays, cell cycle assays, DNA fragmentation assays, transfection efficiency assays, mitochondrial potential assays, cell viability assays, vitality assays, mammalian and aggregated cell assays, whole blood assays, and the companys proprietary FlexiCyte assay for mammalian cell analysis.
ChemoMetec offers NucleoCounter® NC-3000™, XcytoMatic® 40, NucleoCounter® NC-250™, and XcytoMatic® 30.
Yes, ChemoMetec is publicly traded on OMXCOP under the ticker symbol CHEMM.
ChemoMetec has 1 investor. Key investors include European Union.
ChemoMetec operates through Chemometec A/S.